Medicinova (MNOV) Cash from Investing Activities (2010 - 2025)
Medicinova (MNOV) posted quarterly Cash from Investing Activities of $1.0 for Q4 2024, down 95.45% year-over-year from $22.0 in Q1 2024, and down 99.48% quarter-over-quarter from $193.0 in Q3 2024.
Medicinova (MNOV) Cash from Investing Activities (2010 - 2025) Analysis & Trends
Medicinova (MNOV) has reported Cash from Investing Activities for 13 consecutive years, with $1.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Cash from Investing Activities fell 95.45% year-over-year to $1.0; the TTM figure through Dec 2025 stood at $216.0 (up 108.54% YoY), while the FY2025 annual figure was -$2899.0, down 315.93% from the prior year.
- Cash from Investing Activities slipped to $1.0 in Q4 2024 per MNOV's latest filing, from $193.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $39.9 million in Q1 2023 and bottomed at -$30.0 million in Q4 2022.
- Historically, Cash from Investing Activities has averaged $821955.8 across 5 years, with a median of -$1892.0 in 2020.
- Annual changes were most pronounced in 2020 — Cash from Investing Activities tumbled 350.45% — and 2024, when it soared 107.03%.
- Medicinova's Cash from Investing Activities stood at -$32698.0 in 2020, then soared by 91.01% to -$2938.0 in 2021, then plunged by 1021173.32% to -$30.0 million in 2022, then soared by 100.0% to $22.0 in 2023, then plunged by 95.45% to $1.0 in 2024.
- Business Quant data shows MNOV's Cash from Investing Activities at $1.0 in Q4 2024, $193.0 in Q3 2024, and $22.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Medicinova | 68.42 Mn | 68.42 Mn | 317,759.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2,899.00 |
| Sep 30, 2025 | -2,899.00 |
| Dec 31, 2024 | 1.00 |
| Dec 31, 2024 | 1.00 |
| Sep 30, 2024 | 193.00 |
| Sep 30, 2024 | 193.00 |
| Dec 31, 2023 | 22.00 |
| Dec 31, 2023 | 22.00 |
| Sep 30, 2023 | -2,744.00 |
| Sep 30, 2023 | -2,744.00 |
| Jun 30, 2023 | -18,577.00 |
| Jun 30, 2023 | -18,577.00 |
| Mar 31, 2023 | 39.93 Mn |
| Mar 31, 2023 | 39.93 Mn |
| Dec 31, 2022 | -30.01 Mn |
| Dec 31, 2022 | -30.01 Mn |
| Sep 30, 2021 | -2,938.00 |
| Sep 30, 2021 | -2,938.00 |
| Dec 31, 2020 | -32,698.00 |
| Dec 31, 2020 | -32,698.00 |